Edition:
United Kingdom

Penumbra Inc (PEN.N)

PEN.N on New York Stock Exchange

91.35USD
19 Jan 2018
Change (% chg)

$1.25 (+1.39%)
Prev Close
$90.10
Open
$89.70
Day's High
$91.45
Day's Low
$89.70
Volume
38,866
Avg. Vol
44,546
52-wk High
$116.30
52-wk Low
$68.00

Chart for

About

Penumbra, Inc. is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address... (more)

Overall

Beta: --
Market Cap(Mil.): $3,181.32
Shares Outstanding(Mil.): 33.77
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.28 16.58
EPS (TTM): -- -- --
ROI: -- 13.90 10.60
ROE: -- 16.71 14.19

BRIEF-Penumbra Announces Formation of Joint Venture, MVI Health

* PENUMBRA ANNOUNCES THE FORMATION OF JOINT VENTURE, MVI HEALTH

04 Jan 2018

BRIEF-Penumbra posts Q3 revenue of $83.9 million

* Penumbra, Inc. reports third quarter 2017 financial results

07 Nov 2017

BRIEF-Penumbra Q2 loss per share $0.05

* Qtrly net loss per share $0.05 Source text for Eikon: Further company coverage:

08 Aug 2017

Competitors

  Price Chg
Terumo Corp (4543.T) ¥5,430 -30.00
Johnson & Johnson (JNJ.N) $147.36 +0.44
Medtronic PLC (MDT.N) $86.68 -0.58
Stryker Corporation (SYK.N) $161.28 +1.00
Boston Scientific Corporation (BSX.N) $27.65 +0.25

Earnings vs. Estimates